Webcast is supported by an educational grant from:
SCIENTIFIC AGENDA
Session XI: Multimodality therapy for rectal cancer Chairs: Alfredo Carrato, MD, PhD and Bengt Glimelius, MD
Selected abstract: How accurate can USPIO MRI predict the nodal status in primary rectal cancer? G.L. Beets et al.
Selected abstract: Global gene expression profiling of clinical response to radiotherapy and chemoradiotherapy in rectal adenocarcinoma reveals distinct and common molecular mechanisms of action Russell David Petty, MD, et al.
Imaging for rectal cancer Regina G.H. Beets-Tan, MD, PhD
Adequate surgical resection for rectal cancer: The pathologist’s view Phil Quirke, PhD, MRC Path Adequate surgical resection for rectal cancer: The surgeon’s view Bernard Nordlinger, MD What can be expected from preoperative chemoradiotherapy and radiotherapy? Hans-Joachim Schmoll, MD, PhD Discussion based on cases Bengt Glimelius, MD; Bruce D. Minsky, MD; Bernard Nordlinger, MD; Hans- Joachim Schmoll, MD, PhD; Vincenzo Valentini, MD
Adequate surgical resection for rectal cancer: The pathologist’s view Phil Quirke, PhD, MRC Path
Adequate surgical resection for rectal cancer: The surgeon’s view Bernard Nordlinger, MD
What can be expected from preoperative chemoradiotherapy and radiotherapy? Hans-Joachim Schmoll, MD, PhD
Discussion based on cases Bengt Glimelius, MD; Bruce D. Minsky, MD; Bernard Nordlinger, MD; Hans- Joachim Schmoll, MD, PhD; Vincenzo Valentini, MD
The clinical approach to very small rectal tumors Jean-Pierre Gerard, MD
